pre-ipo
Stage
About
Venusmedtech is a Hangzhou-based medical device company specializing in the research, development, and commercialization of transcatheter heart valve therapies for structural heart diseases. The company offers a comprehensive product portfolio for treating aortic, pulmonary, mitral, and tricuspid valve diseases and has a global presence in over 60 countries.
Explore Venusmedtech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.